Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments Corp (NQ: CLOV )

4.200 +0.080 (+1.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clover Health Investments Corp

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
3 SPACs to Sell Before They Go Bust in 2023
Traders are looking for bargains amid busted SPAC stocks. However, these three SPACS to sell should be avoided. 
Via InvestorPlace
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III’s Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Can Q4 Results Help Save Clover Health (CLOV) Stock?
Clover Health (CLOV) stock is on the rise Tuesday thanks to the company's earnings report for the fourth quarter of 2022. 
Via InvestorPlace
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Clover Health Stock Is Rising Today
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading higher Tuesday after the company reported strong fourth-quarter results. 
Via Benzinga
Citigroup Maintains Neutral Rating for Clover Health Investments: Here's What You Need To Know
Via Benzinga
Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early... 
Via Benzinga
I ‘Tricked’ ChatGPT Into Picking Stocks to Buy. Here’s What It Said.
We asked ChatGPT to name various types of stocks to buy. Can the latest artificial intelligence craze get things right? 
Via InvestorPlace
Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning
Today, speculators are bidding up shares of Clovis Oncology and CLVS stock, after the company announced bankruptcy concerns. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
CLOVER HEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating Clover Health Investments Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
How Did Stocks React To The December CPI Print? A Tale Of Two Narratives
Market bets on whether the Federal Reserve's rate hikes would lead to a recession in 2023 have become a primary focus for the equity markets and for those who trade them.  
Via Benzinga
25 Penny Stocks to Sell Before They Die
Wondering which small-cap companies you should offload before 2023? Here are the top picks for penny stocks to sell while you still can. 
Via InvestorPlace
6 Penny Stocks to Sell Right Now … And 1 to Buy
Don't be tempted by the ultra-low price of these penny stocks. All of them are likely headed even lower. 
Via InvestorPlace
7 Penny Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole
Don't let the recent bull market rally fool you into thinking these seven penny stocks to avoid are worthwhile moonshots. 
Via InvestorPlace
7 Stocks Only Suckers Will Own In This Bear Market
Don't purchase any of these sucker stocks to avoid, as a vicious bear market and increased recession risk drives their prices lower. 
Via InvestorPlace
Clover Health Medicare Advantage Plans Earn 3.5 Star Rating for 2023
From Clover Health Investments, Corp.
Via GlobeNewswire
Clover Health Debuts New Medicare Advantage Plans for 2023
From Clover Health Investments, Corp.
Via GlobeNewswire
Billionaire VC Chamath Palihapitiya Sells Clover Health Shares: Is He No Longer Bullish?
Once touted as the SPAC King, Chamath Palihapitiya used blank check companies to take several private companies public. But as the SPAC craze dies out, the billionaire venture capitalist is now... 
Via Benzinga
Why Is FaZe Clan (FAZE) Stock Down 34% Today?
FaZe Clan (FAZE) stock isn't doing so hot on Tuesday as investors start to lose hope in the e-sports company following its SPAC merger. 
Via InvestorPlace
Is Chamath Palihapitiya Giving Up on Clover Health (CLOV) Stock?
CLOV stock needs investors to get through this year's Medicare Advantage marketing wars, but they won't include Chamath Palihapitiya. 
Via InvestorPlace
7 Nasdaq Stocks to Sell Before They Die
With more pain ahead for equities, these seven Nasdaq stocks should be the first to be expelled from investors' portfolios. 
Via InvestorPlace
Chamath Palihapitiya Is Giving Up on IPOF, IPOD Stocks
Both IPOF stock and IPOD stock are now trading at their IPO prices of $10 after Palihapitiya pulled the plug on the SPACs. 
Via InvestorPlace
Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.
Shares of IPOF stock are back at its IPO price of $10 after Chamath Palihapitiya announced a return of capital to shareholders. 
Via InvestorPlace
7 Meme Stocks for Investors to Take Seriously in 2022
These meme stocks have a remarkable growth runway ahead and are trading near historical lows. I wouldn't count them out just yet. 
Via InvestorPlace
Clover Health Investments, Corp. (NASDAQ:CLOV) Investor Alert: Investigation Concerning Possible Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/23/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Clover Health Investments, Corp. 
Via SBWire
Chamath Palihapitiya's SPAC Track Record Means Double-Digit Losses For You. Here Are The Details On All His Deals
Chamath Palihapitiya was one of the biggest names in the SPAC market in 2021 and when times were good for new companies going public, Palihapitiya had some of the best-performing deals of that year. 
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Why Is Norwegian Cruise (NCLH) Stock Down 12% Today?
Norwegian Cruise (NCLH) stock is sinking on Tuesday as investors react to the company's earnings report for the second quarter of 2022. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.